- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04282499
Effects of Exercise Training on Blood Pressure Variability (VARIABILITA')
Comparative Effects of 12-weeks of Aerobic Versus Combined Exercise Training on Short Term Blood Pressure Variability in Patients With Hypertension
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study will be a randomized trial, with two intervention arms: 1) Aerobic training (AT) and 2) Combined training (CT) groups. The planned training period will be 12 weeks for each group. Patients of both groups will be asked to exercise three times a week. Each session will last 80 minutes for each group. Population: We will includ 60 male subjects ≥ 45 years old, with established diagnosis of hypertension (of at least one year), treated with pharmacological therapy and with resting BP values under acceptable control (systolic BP <150 mmHg; diastolic BP < 90 mmHg) at admission. All groups of anti-hypertensive drugs will be admitted; there will be no restriction on the number of anti-hypertensive drugs taken by the patients. Sustained BP increase during the exercise protocol will be managed with the administration of furosemide (25-50 mg/daily). Patients who will need further pharmacological interventions for lowering BP will be withdrawn from the study. The following exclusion criteria will be adopted: secondary hypertension; significant heart valve diseases; signs and or symptoms of myocardial ischemia during ergometric test; neurological and or orthopedic conditions contraindicating or limiting ET; significant COPD (FEV1 <50%), or symptomatic peripheral arterial occlusive disease. Patients will be randomly assigned on 1:1 basis to either AT or CT group. The randomization code will be developed with a computer random-number generator to select random permuted blocks.
Exercise training protocols: AT group: every exercise session will include 10 min of warm-up, cool-down and flexibility exercises and 60 min of aerobic exercise with cycling and treadmill at 60-70% of VO2 peak.
CT group: patients will perform aerobic and resistance exercises in the same session. In order to balance the total amount of exercise, exercise sessions of the CT group will be organized as follow: 40 minutes of aerobic training with cycling and treadmill at 60-70% of VO2 peak; 20 minutes of resistance training including the following exercises: leg press and extension, shoulder press, chest press, low row and vertical traction. all the subjects Each strength exercise will be performed by patients at 60% of their maximal voluntary contraction. Patients of CT group will performed also 10 min of warm-up, cool-down and flexibility exercises. The one maximum repetition test (1RM) will be used to determine the RE load.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
RM
-
Rome, RM, Italy, 00166
- IRCCS San Raffaele Pisana
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- ability to understand the study protocol instructions
- ability to sign the informed consent
Exclusion Criteria:
- sever cardio-vascular condition
- cognitive deficit
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: combined exercise
combined exercise (aerobic+resistance training)
|
Patients will be undergone to aerobic exercises in addition to the resistance training.
|
|
Active Comparator: aerobic exercise
aerobic exercise only
|
Patients will be trained through the aerobic exercises only.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in 24/h systolic blood pressure variability
Time Frame: At baseline (day 1-T1) and at the end (12 weeks-T2) of the treatment.
|
Systolic BP variability will be calculated through the formula of average real variability.
This formula will be applied to the measures of BP obtained during 24 ambulatory BP monitoring
|
At baseline (day 1-T1) and at the end (12 weeks-T2) of the treatment.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in 24/h systolic and diatolic blood pressure values
Time Frame: At baseline (day 1-T1) and at the end (12 weeks-T2) of the treatment.
|
Measures of BP obtained during 24 ambulatory BP monitoring
|
At baseline (day 1-T1) and at the end (12 weeks-T2) of the treatment.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Giuseppe Caminiti, MD, IRCCS San Raffaele Roma
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RP 24/18
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
Clinical Trials on combined exercise
-
Hitit UniversityCompleted
-
Xianjie ZhengCompletedObesity | Overweight | Inflammation, Low-Grade | Cardiovascular Diseases, Risk FactorsChina
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension | Healthy
-
Egas Moniz - Cooperativa de Ensino Superior, CRLCompletedCoronary Arterial Disease (CAD)Portugal
-
Charles University, Czech RepublicMinistry of Health, Czech Republic; EXCELES LX22NPO5104, CarDiaRecruiting
-
Ege UniversityCompletedMigraine | Chronic MigraineTurkey
-
Evangelismos HospitalCompletedHeart Failure | Diastolic DysfunctionGreece
-
Eastern Mediterranean UniversityUnknownThe Effect of Exercise Training on Balance and Functional Status in Individuals With Osteoarthritis'Osteo Arthritis Knee | BalanceCyprus
-
University of MosulCompletedChronic Pain | Rehabilitation | Physical Therapy | Rural HealthIraq
-
Maria Gabriela Aké PalomoUniversidad Autónoma de YucatánCompletedDiabetes Mellitus, Type 2 | Neuropathic Pain | Neuropathy, DiabeticMexico